Realistic pathologic classification of acute myeloid leukemias

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Current acute myeloid leukemia (AML) classification predominantly uses French-American-British (FAB) criteria.
• The World Health Organization (WHO) proposed a new AML classification incorporating cytogenetic findings and myelodysplasia.
• The WHO system presents challenges with numerous categories, unclear clinical significance, and diagnostic overlap.

Purpose of the Study:

• To propose a practical pathological classification for AML.
• To develop a system that reliably identifies AML subtypes using morphology and immunophenotyping.
• To integrate cytogenetic translocations and myelodysplastic changes into AML classification.

Main Methods:

• Review and critique of existing AML classification systems (FAB and WHO).
• Proposal of a new classification based on clinicopathologic correlations.
• Emphasis on diagnostic methods including morphologic evaluation, immunophenotyping, and cytogenetic/molecular genetic studies.

Main Results:

• The proposed classification includes AML types linked to specific cytogenetic translocations.
• It recognizes AML associated with myelodysplastic changes.
• The system is designed for reliable diagnosis using established pathological techniques.

Conclusions:

• The proposed AML classification offers a realistic approach integrating morphology, immunophenotyping, and genetics.
• This system addresses limitations of current WHO and FAB classifications.
• It provides a framework for future identification and classification of novel AML entities.